- undefined
- undefined
- undefined
- undefined
-
- ¡Intentar construir su término de la búsqueda una a la vez, y ser tan específico como usted puede! Buscar el ejemplo del término: “tos crónica”.
- No incorporar los resultados múltiples tales como "anemia, tos crónica, pérdida de peso, vomitando" todos al mismo tiempo.
- Después de seleccionar su término de la búsqueda resulta una lista de diagnosis posibles será generada. Si la lista es demasiado larga, usted podrá enangostarla abajo incorporando términos adicionales.
- No incorporar los valores tales como "ritmo 110 del corazón" o "sodio 125", en lugar uso "taquicardia" o "hyponatremia".
Información de la droga para FEMCON Fe (norethindrone and ethinyl estradiol tablets,chewable and ferrous fumarate tablets) 0.4 mg / 35 mcg (Warner Chilcott (US), LLC): PRINCIPAL DISPLAY PANEL
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- INFORMATION FOR THE PATIENT
- ADVERSE REACTIONS
- OVERDOSAGE
- NONCONTRACEPTIVE HEALTH BENEFITS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- PATIENT BRIEF SUMMARY
- DETAILED PATIENT PACKAGE INSERT
- PRINCIPAL DISPLAY PANEL

FEMCON® Fe(norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg/35 mcgchewable
Five PATIENT INSERTS are enclosed for your use when dispensing FEMCON® Fe.
Additional copies are available from Warner Chilcott (US), LLC100 Enterprise DriveRockaway, NJ 07866
See bottom flap for lot number and expiration date.
Each of the 21 WHITE tablets containsnorethindrone (0.4 mg) and ethinyl estradiol (35 mcg).Each BROWN tablets containsferrous fumarate (75 mg).
Dosage: 1 tablet daily as prescribed.See Package Insert enclosed for completePrescribing Information.
5 Blister Cards of28 Tablets EachFerrous Fumaratetablets are not USP for dissolution and assay.
This product (like all oral contraceptives) is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases.
Store at 25° C (77° F); excursions permitted to 15°- 30° C (59°- 86° F) [see USP Controlled Room Temperature].
- Drug Information Provided by National Library of Medicine (NLM).